Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy, such as fluorouracil, work in different ways to stop tumor cells
from dividing so they stop growing or die. Suramin may increase the effectiveness of
fluorouracil by making tumor cells more sensitive to the drug. This phase I/II trial is
studying the side effects and best dose of fluorouracil and the chemosensitizer suramin and
to see how well they work in treating patients with metastatic renal cell (kidney) cancer.